FGFR

CAT # Magaca Alaabta Sharaxaada
CPD100464 Erdafitinib Erdafitinib, oo sidoo kale loo yaqaan JNJ-42756493, waa awood xoog leh oo la dooran karo oo afka laga heli karo, pan-fibroblast factor receptor (FGFR) inhibitor oo leh firfircoonida antineoplastic. Marka la maamulo afka, JNJ-42756493 waxay ku xidhan tahay oo ay joojisaa FGFR, taas oo keeni karta in la joojiyo dariiqyada gudbinta calaamadaha FGFR ee la xidhiidha iyo sidaas awgeed xannibaadda kordhinta unugyada burooyinka iyo dhimashada unugyada burooyinka ee FGFR-soo-saarka unugyada burooyinka. FGFR, oo lagu hagaajiyay noocyo badan oo unugyo burooyin ah, ayaa ah reseptor tyrosine kinase lagama maarmaan u ah kororka unugyada burooyinka, kala duwanaanta iyo badbaadada.
CPD3618 TAS-120 TAS-120 waa xannibaadaha afka laga heli karo ee soo-dhoweeyaha koritaanka fibroblast (FGFR) oo leh firfircoonida antineoplastic ee suurtagalka ah. FGFR inhibitor TAS-120 ayaa si xushmad leh oo aan leexleexad lahayn u xidhaa oo joojisa FGFR, taas oo keeni karta in la joojiyo labadaba dariiqa gudbinta calaamada dhexdhexaadka ah ee FGFR iyo kororka unugyada burooyinka, iyo korodhka dhimashada unugyada ee FGFR-gacanta unugyada burooyinka. FGFR waa tayroosin kinase reseptor ah oo lagama maarmaan u ah kororka unugyada burooyinka, kala soocida iyo badbaadada iyo muujinteeda ayaa lagu hagaajiyay noocyo badan oo unugyo burooyin ah.
CPDB1093 Derazantinib; ARQ-087 Derazantinib, oo sidoo kale loo yaqaan ARQ-087, waa xannibaadaha afka laga heli karo ee soo-dhoweeyaha koritaanka fibroblast (FGFR) oo leh firfircoonida antineoplastic ee suurtagalka ah.
CPDB0942 BLU-554 BLU-554 waa fayraska koritaanka fibroblast 4 (FGFR4) inhibitor oo awood u leh daaweynta kansarka hepatocellular iyo cholangiocarcinoma.
CPD0999 H3B-6527 H3B-6527 (H3 Biomedicine) waa horjooge FGFR4 aadka loo xushay oo leh firfircoonida antitumour ee FGF19 ee xadhkaha gacanta iyo jiirarka.
CPD0997 FGF401 FGF-401 waa horjooge FGFR4 ah oo laga soosaaray patent WO2015059668A1, tusaale isku dhafan 83; wuxuu leeyahay IC50 oo ah 1.9 nM.
CPDB0053 AZD4547 AZD 4547 waa horjooge door ah oo ka mid ah soo-dhoweeyaha koritaanka fibroblast (FGFR) tyrosine kinase oo leh IC50 qiimaha 0.2, 2.5, iyo 1.8 nM ee FGFR1, 2, iyo 3, siday u kala horreeyaan.
CPD3610 BLU-9931 BLU9931 waa mid awood leh, la xushay, oo aan laga noqon karin FGFR4 horjooge leh IC50 ee 3 nM, qiyaastii 297-, 184-, iyo 50-laab xulashada FGFR1/2/3, siday u kala horreeyaan.
oo

Nala Soo Xidhiidh

Weydiin

Wararkii Ugu Danbeeyay

  • 7-da Isbeddel ee ugu Sarreysa ee Cilmi-baarista Dawooyinka 2018

    7-da Isbeddel ee ugu Sarreysa Cilmi-baarista Dawooyinka Waxaan...

    Iyadoo lagu jiro cadaadis sii kordhaya si loogu tartamo jawi dhaqaale iyo teknoloji oo adag, shirkadaha dawooyinka iyo bayoolojiga waa inay si joogto ah u cusbooneysiiyaan barnaamijyadooda R&D si ay horay ugu sii socdaan ...

  • ARS-1620: Horjooge cusub oo rajo leh oo loogu talagalay kansarka-KRAS-mutant

    ARS-1620: Horjooge cusub oo rajo leh oo loogu talagalay K...

    Sida laga soo xigtay cilmi-baaris lagu daabacay Cell, cilmi-baarayaashu waxay sameeyeen xannibaado gaar ah oo loogu talagalay KRASG12C oo loo yaqaan ARS-1602 taas oo keentay dib u noqoshada buro ee jiirarka. "Daraasaddani waxay ku siinaysaa caddayn vivo ah in KRAS mutant uu noqon karo ...

  • AstraZeneca waxay heshaa kor u qaadida sharciyeynta ee daawooyinka kansarka

    AstraZeneca waxay heshay kor u qaadida sharciyeynta ee...

    AstraZeneca waxay heshay labanlaab kor u qaadis ah faylalka Oncology Talaadadii, ka dib markii sharciyeeyayaasha Mareykanka iyo Yurub ay aqbaleen soo gudbinta sharciyeynta dawooyinkeeda, tallaabada ugu horreysa ee lagu guuleysto oggolaanshaha daawooyinkan. ...

WhatsApp Online chat!